Global Topical Pain Relief Market

Topical Pain Relief Comprehensive Study by Type (Prescription Pain Relief Products, Over-the-counter (OTC) Pain Relief Products), Application (Pets, Mammals, Farm Animals), Distribution Channel (Pharmacies & Drug Stores, Retail & Grocery Stores, E-Commerce), Formulation (Cream, Spray, Gel, Patch, Others), Therapeutic Class (Non-Opioids, Opioids) Players and Region - Global Market Outlook to 2028

Topical Pain Relief Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 7.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Topical Pain Relief
Topical pain relief medications comprises pain killers which are directly applied, sprayed or rubbed on the skin over painful muscles or joints. Topical pain relief medications are intended to relieve pain as they contain different ingredients like capsaicin, opioids, salicylates, nonsteroidal anti-inflammatory drugs (NSAIDS), as well as others. These products have a cooling or heating effect which stimulate the nerves near the pain point & so relieve the pain. When pain is localized, patients greatly prefer topical treatments as adjunctive therapy that can be as effective as oral treatments & cause fewer side effects.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia-Pacific
UnitValue (USD Million)
CAGR7.3%


Analyst at AMA Research estimates that United Kingdom, and United States Players will contribute the maximum growth to Global Topical Pain Relief market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Novartis International AG (Switzerland), Johnson & Johnson (United States), GlaxoSmithKline plc. (United Kingdom), Pfizer Inc. (United States), Reckitt Benckiser Group Plc. (United Kingdom), Sanofi S.A. (France), Topical BioMedics, Inc. (United States), AdvaCare Pharma (United States), Sun Pharmaceutical Industries Limited (India) and Troy Healthcare, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Emami Group (India), Exzell Pharma Inc. (Canada) and Performance Health Technologies, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Topical Pain Relief market by Type (Prescription Pain Relief Products and Over-the-counter (OTC) Pain Relief Products), Application (Pets, Mammals and Farm Animals) and Region.



On the basis of geography, the market of Topical Pain Relief has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. If we see Market by Distribution Channel, the sub-segment i.e. Pharmacies & Drug Stores will boost the Topical Pain Relief market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Formulation, the sub-segment i.e. Cream will boost the Topical Pain Relief market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapeutic Class, the sub-segment i.e. Non-Opioids will boost the Topical Pain Relief market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing demand for topical pain relief products by sportsperson

Market Growth Drivers:
Increase in Prevalence of Arthritis, Increasing geriatric population and Slighter Side Effects Caused by Topical Pain Relief Products in Comparison with Oral Medicines

Restraints:
Skin Irritants Caused by Topical Pain Relief

Opportunities:
Arrival of online pharmacy and Opportunities in emerging markets

Market Leaders and their expansionary development strategies
In March 2019, Alcon, a division of Novartis, announced that it has acquired PowerVision, Inc. Acquired Company is a private, United States based medical device development company that focuses on creating fluid-based intraocular lens implants. This acquisition supports Alcon's commitment to bring this innovative, accommodating lens to cataract patients throughout the world.



Analyst View
By therapeutic class, the global topical pain relief market is segmented into non-opioids [capsaicin, nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, lidocaine, other non-opioids] and opioids [buprenorphine and fentanyl]

Key Target Audience
Topical Pain Relief Product Manufacturers, Healthcare Service Providers, Distributors and Suppliers, Research Laboratories and Academic Institutes, Original Equipment Manufacturers (OEMs), Market Research Companies, Raw Materials Suppliers, Government, Industry Associations, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Prescription Pain Relief Products
  • Over-the-counter (OTC) Pain Relief Products
By Application
  • Pets
  • Mammals
  • Farm Animals
By Distribution Channel
  • Pharmacies & Drug Stores
  • Retail & Grocery Stores
  • E-Commerce

By Formulation
  • Cream
  • Spray
  • Gel
  • Patch
  • Others

By Therapeutic Class
  • Non-Opioids
  • Opioids

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Arthritis
      • 3.2.2. Increasing geriatric population
      • 3.2.3. Slighter Side Effects Caused by Topical Pain Relief Products in Comparison with Oral Medicines
    • 3.3. Market Trends
      • 3.3.1. Growing demand for topical pain relief products by sportsperson
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Topical Pain Relief, by Type, Application, Distribution Channel, Formulation, Therapeutic Class and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Topical Pain Relief (Value)
      • 5.2.1. Global Topical Pain Relief by: Type (Value)
        • 5.2.1.1. Prescription Pain Relief Products
        • 5.2.1.2. Over-the-counter (OTC) Pain Relief Products
      • 5.2.2. Global Topical Pain Relief by: Application (Value)
        • 5.2.2.1. Pets
        • 5.2.2.2. Mammals
        • 5.2.2.3. Farm Animals
      • 5.2.3. Global Topical Pain Relief by: Distribution Channel (Value)
        • 5.2.3.1. Pharmacies & Drug Stores
        • 5.2.3.2. Retail & Grocery Stores
        • 5.2.3.3. E-Commerce
      • 5.2.4. Global Topical Pain Relief by: Formulation (Value)
        • 5.2.4.1. Cream
        • 5.2.4.2. Spray
        • 5.2.4.3. Gel
        • 5.2.4.4. Patch
        • 5.2.4.5. Others
      • 5.2.5. Global Topical Pain Relief by: Therapeutic Class (Value)
        • 5.2.5.1. Non-Opioids
        • 5.2.5.2. Opioids
      • 5.2.6. Global Topical Pain Relief Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Topical Pain Relief (Volume)
      • 5.3.1. Global Topical Pain Relief by: Type (Volume)
        • 5.3.1.1. Prescription Pain Relief Products
        • 5.3.1.2. Over-the-counter (OTC) Pain Relief Products
      • 5.3.2. Global Topical Pain Relief by: Application (Volume)
        • 5.3.2.1. Pets
        • 5.3.2.2. Mammals
        • 5.3.2.3. Farm Animals
      • 5.3.3. Global Topical Pain Relief by: Distribution Channel (Volume)
        • 5.3.3.1. Pharmacies & Drug Stores
        • 5.3.3.2. Retail & Grocery Stores
        • 5.3.3.3. E-Commerce
      • 5.3.4. Global Topical Pain Relief by: Formulation (Volume)
        • 5.3.4.1. Cream
        • 5.3.4.2. Spray
        • 5.3.4.3. Gel
        • 5.3.4.4. Patch
        • 5.3.4.5. Others
      • 5.3.5. Global Topical Pain Relief by: Therapeutic Class (Volume)
        • 5.3.5.1. Non-Opioids
        • 5.3.5.2. Opioids
      • 5.3.6. Global Topical Pain Relief Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Topical Pain Relief (Price)
      • 5.4.1. Global Topical Pain Relief by: Type (Price)
  • 6. Topical Pain Relief: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis International AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline plc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Reckitt Benckiser Group Plc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi S.A. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Topical BioMedics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AdvaCare Pharma (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sun Pharmaceutical Industries Limited (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Troy Healthcare, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Topical Pain Relief Sale, by Type, Application, Distribution Channel, Formulation, Therapeutic Class and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Topical Pain Relief (Value)
      • 7.2.1. Global Topical Pain Relief by: Type (Value)
        • 7.2.1.1. Prescription Pain Relief Products
        • 7.2.1.2. Over-the-counter (OTC) Pain Relief Products
      • 7.2.2. Global Topical Pain Relief by: Application (Value)
        • 7.2.2.1. Pets
        • 7.2.2.2. Mammals
        • 7.2.2.3. Farm Animals
      • 7.2.3. Global Topical Pain Relief by: Distribution Channel (Value)
        • 7.2.3.1. Pharmacies & Drug Stores
        • 7.2.3.2. Retail & Grocery Stores
        • 7.2.3.3. E-Commerce
      • 7.2.4. Global Topical Pain Relief by: Formulation (Value)
        • 7.2.4.1. Cream
        • 7.2.4.2. Spray
        • 7.2.4.3. Gel
        • 7.2.4.4. Patch
        • 7.2.4.5. Others
      • 7.2.5. Global Topical Pain Relief by: Therapeutic Class (Value)
        • 7.2.5.1. Non-Opioids
        • 7.2.5.2. Opioids
      • 7.2.6. Global Topical Pain Relief Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Topical Pain Relief (Volume)
      • 7.3.1. Global Topical Pain Relief by: Type (Volume)
        • 7.3.1.1. Prescription Pain Relief Products
        • 7.3.1.2. Over-the-counter (OTC) Pain Relief Products
      • 7.3.2. Global Topical Pain Relief by: Application (Volume)
        • 7.3.2.1. Pets
        • 7.3.2.2. Mammals
        • 7.3.2.3. Farm Animals
      • 7.3.3. Global Topical Pain Relief by: Distribution Channel (Volume)
        • 7.3.3.1. Pharmacies & Drug Stores
        • 7.3.3.2. Retail & Grocery Stores
        • 7.3.3.3. E-Commerce
      • 7.3.4. Global Topical Pain Relief by: Formulation (Volume)
        • 7.3.4.1. Cream
        • 7.3.4.2. Spray
        • 7.3.4.3. Gel
        • 7.3.4.4. Patch
        • 7.3.4.5. Others
      • 7.3.5. Global Topical Pain Relief by: Therapeutic Class (Volume)
        • 7.3.5.1. Non-Opioids
        • 7.3.5.2. Opioids
      • 7.3.6. Global Topical Pain Relief Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Topical Pain Relief (Price)
      • 7.4.1. Global Topical Pain Relief by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Topical Pain Relief: by Type(USD Million)
  • Table 2. Topical Pain Relief Prescription Pain Relief Products , by Region USD Million (2017-2022)
  • Table 3. Topical Pain Relief Over-the-counter (OTC) Pain Relief Products , by Region USD Million (2017-2022)
  • Table 4. Topical Pain Relief: by Application(USD Million)
  • Table 5. Topical Pain Relief Pets , by Region USD Million (2017-2022)
  • Table 6. Topical Pain Relief Mammals , by Region USD Million (2017-2022)
  • Table 7. Topical Pain Relief Farm Animals , by Region USD Million (2017-2022)
  • Table 8. Topical Pain Relief: by Distribution Channel(USD Million)
  • Table 9. Topical Pain Relief Pharmacies & Drug Stores , by Region USD Million (2017-2022)
  • Table 10. Topical Pain Relief Retail & Grocery Stores , by Region USD Million (2017-2022)
  • Table 11. Topical Pain Relief E-Commerce , by Region USD Million (2017-2022)
  • Table 12. Topical Pain Relief: by Formulation(USD Million)
  • Table 13. Topical Pain Relief Cream , by Region USD Million (2017-2022)
  • Table 14. Topical Pain Relief Spray , by Region USD Million (2017-2022)
  • Table 15. Topical Pain Relief Gel , by Region USD Million (2017-2022)
  • Table 16. Topical Pain Relief Patch , by Region USD Million (2017-2022)
  • Table 17. Topical Pain Relief Others , by Region USD Million (2017-2022)
  • Table 18. Topical Pain Relief: by Therapeutic Class(USD Million)
  • Table 19. Topical Pain Relief Non-Opioids , by Region USD Million (2017-2022)
  • Table 20. Topical Pain Relief Opioids , by Region USD Million (2017-2022)
  • Table 21. South America Topical Pain Relief, by Country USD Million (2017-2022)
  • Table 22. South America Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 23. South America Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 24. South America Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 25. South America Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 26. South America Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 27. Brazil Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 28. Brazil Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 29. Brazil Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 30. Brazil Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 31. Brazil Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 32. Argentina Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 33. Argentina Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 34. Argentina Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 35. Argentina Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 36. Argentina Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 37. Rest of South America Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 38. Rest of South America Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 39. Rest of South America Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 40. Rest of South America Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 41. Rest of South America Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 42. Asia Pacific Topical Pain Relief, by Country USD Million (2017-2022)
  • Table 43. Asia Pacific Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 44. Asia Pacific Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 45. Asia Pacific Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 46. Asia Pacific Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 47. Asia Pacific Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 48. China Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 49. China Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 50. China Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 51. China Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 52. China Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 53. Japan Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 54. Japan Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 55. Japan Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 56. Japan Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 57. Japan Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 58. India Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 59. India Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 60. India Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 61. India Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 62. India Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 63. South Korea Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 64. South Korea Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 65. South Korea Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 66. South Korea Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 67. South Korea Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 68. Taiwan Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 69. Taiwan Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 70. Taiwan Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 71. Taiwan Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 72. Taiwan Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 73. Australia Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 74. Australia Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 75. Australia Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 76. Australia Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 77. Australia Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 83. Europe Topical Pain Relief, by Country USD Million (2017-2022)
  • Table 84. Europe Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 85. Europe Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 86. Europe Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 87. Europe Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 88. Europe Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 89. Germany Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 90. Germany Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 91. Germany Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 92. Germany Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 93. Germany Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 94. France Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 95. France Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 96. France Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 97. France Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 98. France Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 99. Italy Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 100. Italy Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 101. Italy Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 102. Italy Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 103. Italy Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 104. United Kingdom Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 105. United Kingdom Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 106. United Kingdom Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 107. United Kingdom Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 108. United Kingdom Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 109. Netherlands Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 110. Netherlands Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 111. Netherlands Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 112. Netherlands Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 113. Netherlands Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 114. Rest of Europe Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 115. Rest of Europe Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 116. Rest of Europe Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 117. Rest of Europe Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 118. Rest of Europe Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 119. MEA Topical Pain Relief, by Country USD Million (2017-2022)
  • Table 120. MEA Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 121. MEA Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 122. MEA Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 123. MEA Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 124. MEA Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 125. Middle East Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 126. Middle East Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 127. Middle East Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 128. Middle East Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 129. Middle East Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 130. Africa Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 131. Africa Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 132. Africa Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 133. Africa Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 134. Africa Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 135. North America Topical Pain Relief, by Country USD Million (2017-2022)
  • Table 136. North America Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 137. North America Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 138. North America Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 139. North America Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 140. North America Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 141. United States Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 142. United States Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 143. United States Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 144. United States Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 145. United States Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 146. Canada Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 147. Canada Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 148. Canada Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 149. Canada Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 150. Canada Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 151. Mexico Topical Pain Relief, by Type USD Million (2017-2022)
  • Table 152. Mexico Topical Pain Relief, by Application USD Million (2017-2022)
  • Table 153. Mexico Topical Pain Relief, by Distribution Channel USD Million (2017-2022)
  • Table 154. Mexico Topical Pain Relief, by Formulation USD Million (2017-2022)
  • Table 155. Mexico Topical Pain Relief, by Therapeutic Class USD Million (2017-2022)
  • Table 156. Topical Pain Relief Sales: by Type(K Units)
  • Table 157. Topical Pain Relief Sales Prescription Pain Relief Products , by Region K Units (2017-2022)
  • Table 158. Topical Pain Relief Sales Over-the-counter (OTC) Pain Relief Products , by Region K Units (2017-2022)
  • Table 159. Topical Pain Relief Sales: by Application(K Units)
  • Table 160. Topical Pain Relief Sales Pets , by Region K Units (2017-2022)
  • Table 161. Topical Pain Relief Sales Mammals , by Region K Units (2017-2022)
  • Table 162. Topical Pain Relief Sales Farm Animals , by Region K Units (2017-2022)
  • Table 163. Topical Pain Relief Sales: by Distribution Channel(K Units)
  • Table 164. Topical Pain Relief Sales Pharmacies & Drug Stores , by Region K Units (2017-2022)
  • Table 165. Topical Pain Relief Sales Retail & Grocery Stores , by Region K Units (2017-2022)
  • Table 166. Topical Pain Relief Sales E-Commerce , by Region K Units (2017-2022)
  • Table 167. Topical Pain Relief Sales: by Formulation(K Units)
  • Table 168. Topical Pain Relief Sales Cream , by Region K Units (2017-2022)
  • Table 169. Topical Pain Relief Sales Spray , by Region K Units (2017-2022)
  • Table 170. Topical Pain Relief Sales Gel , by Region K Units (2017-2022)
  • Table 171. Topical Pain Relief Sales Patch , by Region K Units (2017-2022)
  • Table 172. Topical Pain Relief Sales Others , by Region K Units (2017-2022)
  • Table 173. Topical Pain Relief Sales: by Therapeutic Class(K Units)
  • Table 174. Topical Pain Relief Sales Non-Opioids , by Region K Units (2017-2022)
  • Table 175. Topical Pain Relief Sales Opioids , by Region K Units (2017-2022)
  • Table 176. South America Topical Pain Relief Sales, by Country K Units (2017-2022)
  • Table 177. South America Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 178. South America Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 179. South America Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 180. South America Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 181. South America Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 182. Brazil Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 183. Brazil Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 184. Brazil Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 185. Brazil Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 186. Brazil Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 187. Argentina Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 188. Argentina Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 189. Argentina Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 190. Argentina Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 191. Argentina Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 192. Rest of South America Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 193. Rest of South America Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 194. Rest of South America Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 195. Rest of South America Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 196. Rest of South America Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 197. Asia Pacific Topical Pain Relief Sales, by Country K Units (2017-2022)
  • Table 198. Asia Pacific Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 199. Asia Pacific Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 200. Asia Pacific Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 201. Asia Pacific Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 202. Asia Pacific Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 203. China Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 204. China Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 205. China Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 206. China Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 207. China Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 208. Japan Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 209. Japan Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 210. Japan Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 211. Japan Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 212. Japan Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 213. India Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 214. India Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 215. India Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 216. India Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 217. India Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 218. South Korea Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 219. South Korea Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 220. South Korea Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 221. South Korea Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 222. South Korea Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 223. Taiwan Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 224. Taiwan Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 225. Taiwan Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 226. Taiwan Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 227. Taiwan Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 228. Australia Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 229. Australia Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 230. Australia Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 231. Australia Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 232. Australia Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 233. Rest of Asia-Pacific Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 234. Rest of Asia-Pacific Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 235. Rest of Asia-Pacific Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 236. Rest of Asia-Pacific Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 237. Rest of Asia-Pacific Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 238. Europe Topical Pain Relief Sales, by Country K Units (2017-2022)
  • Table 239. Europe Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 240. Europe Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 241. Europe Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 242. Europe Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 243. Europe Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 244. Germany Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 245. Germany Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 246. Germany Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 247. Germany Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 248. Germany Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 249. France Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 250. France Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 251. France Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 252. France Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 253. France Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 254. Italy Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 255. Italy Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 256. Italy Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 257. Italy Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 258. Italy Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 259. United Kingdom Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 260. United Kingdom Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 261. United Kingdom Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 262. United Kingdom Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 263. United Kingdom Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 264. Netherlands Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 265. Netherlands Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 266. Netherlands Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 267. Netherlands Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 268. Netherlands Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 269. Rest of Europe Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 270. Rest of Europe Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 271. Rest of Europe Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 272. Rest of Europe Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 273. Rest of Europe Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 274. MEA Topical Pain Relief Sales, by Country K Units (2017-2022)
  • Table 275. MEA Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 276. MEA Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 277. MEA Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 278. MEA Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 279. MEA Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 280. Middle East Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 281. Middle East Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 282. Middle East Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 283. Middle East Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 284. Middle East Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 285. Africa Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 286. Africa Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 287. Africa Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 288. Africa Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 289. Africa Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 290. North America Topical Pain Relief Sales, by Country K Units (2017-2022)
  • Table 291. North America Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 292. North America Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 293. North America Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 294. North America Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 295. North America Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 296. United States Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 297. United States Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 298. United States Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 299. United States Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 300. United States Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 301. Canada Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 302. Canada Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 303. Canada Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 304. Canada Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 305. Canada Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 306. Mexico Topical Pain Relief Sales, by Type K Units (2017-2022)
  • Table 307. Mexico Topical Pain Relief Sales, by Application K Units (2017-2022)
  • Table 308. Mexico Topical Pain Relief Sales, by Distribution Channel K Units (2017-2022)
  • Table 309. Mexico Topical Pain Relief Sales, by Formulation K Units (2017-2022)
  • Table 310. Mexico Topical Pain Relief Sales, by Therapeutic Class K Units (2017-2022)
  • Table 311. Topical Pain Relief: by Type(USD/Units)
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Topical Pain Relief: by Type(USD Million)
  • Table 323. Topical Pain Relief Prescription Pain Relief Products , by Region USD Million (2023-2028)
  • Table 324. Topical Pain Relief Over-the-counter (OTC) Pain Relief Products , by Region USD Million (2023-2028)
  • Table 325. Topical Pain Relief: by Application(USD Million)
  • Table 326. Topical Pain Relief Pets , by Region USD Million (2023-2028)
  • Table 327. Topical Pain Relief Mammals , by Region USD Million (2023-2028)
  • Table 328. Topical Pain Relief Farm Animals , by Region USD Million (2023-2028)
  • Table 329. Topical Pain Relief: by Distribution Channel(USD Million)
  • Table 330. Topical Pain Relief Pharmacies & Drug Stores , by Region USD Million (2023-2028)
  • Table 331. Topical Pain Relief Retail & Grocery Stores , by Region USD Million (2023-2028)
  • Table 332. Topical Pain Relief E-Commerce , by Region USD Million (2023-2028)
  • Table 333. Topical Pain Relief: by Formulation(USD Million)
  • Table 334. Topical Pain Relief Cream , by Region USD Million (2023-2028)
  • Table 335. Topical Pain Relief Spray , by Region USD Million (2023-2028)
  • Table 336. Topical Pain Relief Gel , by Region USD Million (2023-2028)
  • Table 337. Topical Pain Relief Patch , by Region USD Million (2023-2028)
  • Table 338. Topical Pain Relief Others , by Region USD Million (2023-2028)
  • Table 339. Topical Pain Relief: by Therapeutic Class(USD Million)
  • Table 340. Topical Pain Relief Non-Opioids , by Region USD Million (2023-2028)
  • Table 341. Topical Pain Relief Opioids , by Region USD Million (2023-2028)
  • Table 342. South America Topical Pain Relief, by Country USD Million (2023-2028)
  • Table 343. South America Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 344. South America Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 345. South America Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 346. South America Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 347. South America Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 348. Brazil Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 349. Brazil Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 350. Brazil Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 351. Brazil Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 352. Brazil Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 353. Argentina Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 354. Argentina Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 355. Argentina Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 356. Argentina Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 357. Argentina Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 358. Rest of South America Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 359. Rest of South America Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 360. Rest of South America Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 361. Rest of South America Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 362. Rest of South America Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 363. Asia Pacific Topical Pain Relief, by Country USD Million (2023-2028)
  • Table 364. Asia Pacific Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 365. Asia Pacific Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 366. Asia Pacific Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 367. Asia Pacific Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 368. Asia Pacific Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 369. China Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 370. China Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 371. China Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 372. China Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 373. China Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 374. Japan Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 375. Japan Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 376. Japan Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 377. Japan Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 378. Japan Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 379. India Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 380. India Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 381. India Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 382. India Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 383. India Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 384. South Korea Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 385. South Korea Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 386. South Korea Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 387. South Korea Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 388. South Korea Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 389. Taiwan Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 390. Taiwan Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 391. Taiwan Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 392. Taiwan Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 393. Taiwan Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 394. Australia Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 395. Australia Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 396. Australia Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 397. Australia Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 398. Australia Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 399. Rest of Asia-Pacific Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 400. Rest of Asia-Pacific Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 401. Rest of Asia-Pacific Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 402. Rest of Asia-Pacific Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 403. Rest of Asia-Pacific Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 404. Europe Topical Pain Relief, by Country USD Million (2023-2028)
  • Table 405. Europe Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 406. Europe Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 407. Europe Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 408. Europe Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 409. Europe Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 410. Germany Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 411. Germany Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 412. Germany Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 413. Germany Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 414. Germany Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 415. France Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 416. France Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 417. France Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 418. France Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 419. France Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 420. Italy Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 421. Italy Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 422. Italy Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 423. Italy Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 424. Italy Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 425. United Kingdom Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 426. United Kingdom Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 427. United Kingdom Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 428. United Kingdom Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 429. United Kingdom Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 430. Netherlands Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 431. Netherlands Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 432. Netherlands Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 433. Netherlands Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 434. Netherlands Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 435. Rest of Europe Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 436. Rest of Europe Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 437. Rest of Europe Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 438. Rest of Europe Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 439. Rest of Europe Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 440. MEA Topical Pain Relief, by Country USD Million (2023-2028)
  • Table 441. MEA Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 442. MEA Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 443. MEA Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 444. MEA Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 445. MEA Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 446. Middle East Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 447. Middle East Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 448. Middle East Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 449. Middle East Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 450. Middle East Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 451. Africa Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 452. Africa Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 453. Africa Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 454. Africa Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 455. Africa Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 456. North America Topical Pain Relief, by Country USD Million (2023-2028)
  • Table 457. North America Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 458. North America Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 459. North America Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 460. North America Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 461. North America Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 462. United States Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 463. United States Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 464. United States Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 465. United States Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 466. United States Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 467. Canada Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 468. Canada Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 469. Canada Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 470. Canada Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 471. Canada Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 472. Mexico Topical Pain Relief, by Type USD Million (2023-2028)
  • Table 473. Mexico Topical Pain Relief, by Application USD Million (2023-2028)
  • Table 474. Mexico Topical Pain Relief, by Distribution Channel USD Million (2023-2028)
  • Table 475. Mexico Topical Pain Relief, by Formulation USD Million (2023-2028)
  • Table 476. Mexico Topical Pain Relief, by Therapeutic Class USD Million (2023-2028)
  • Table 477. Topical Pain Relief Sales: by Type(K Units)
  • Table 478. Topical Pain Relief Sales Prescription Pain Relief Products , by Region K Units (2023-2028)
  • Table 479. Topical Pain Relief Sales Over-the-counter (OTC) Pain Relief Products , by Region K Units (2023-2028)
  • Table 480. Topical Pain Relief Sales: by Application(K Units)
  • Table 481. Topical Pain Relief Sales Pets , by Region K Units (2023-2028)
  • Table 482. Topical Pain Relief Sales Mammals , by Region K Units (2023-2028)
  • Table 483. Topical Pain Relief Sales Farm Animals , by Region K Units (2023-2028)
  • Table 484. Topical Pain Relief Sales: by Distribution Channel(K Units)
  • Table 485. Topical Pain Relief Sales Pharmacies & Drug Stores , by Region K Units (2023-2028)
  • Table 486. Topical Pain Relief Sales Retail & Grocery Stores , by Region K Units (2023-2028)
  • Table 487. Topical Pain Relief Sales E-Commerce , by Region K Units (2023-2028)
  • Table 488. Topical Pain Relief Sales: by Formulation(K Units)
  • Table 489. Topical Pain Relief Sales Cream , by Region K Units (2023-2028)
  • Table 490. Topical Pain Relief Sales Spray , by Region K Units (2023-2028)
  • Table 491. Topical Pain Relief Sales Gel , by Region K Units (2023-2028)
  • Table 492. Topical Pain Relief Sales Patch , by Region K Units (2023-2028)
  • Table 493. Topical Pain Relief Sales Others , by Region K Units (2023-2028)
  • Table 494. Topical Pain Relief Sales: by Therapeutic Class(K Units)
  • Table 495. Topical Pain Relief Sales Non-Opioids , by Region K Units (2023-2028)
  • Table 496. Topical Pain Relief Sales Opioids , by Region K Units (2023-2028)
  • Table 497. South America Topical Pain Relief Sales, by Country K Units (2023-2028)
  • Table 498. South America Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 499. South America Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 500. South America Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 501. South America Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 502. South America Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 503. Brazil Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 504. Brazil Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 505. Brazil Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 506. Brazil Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 507. Brazil Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 508. Argentina Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 509. Argentina Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 510. Argentina Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 511. Argentina Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 512. Argentina Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 513. Rest of South America Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 514. Rest of South America Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 515. Rest of South America Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 516. Rest of South America Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 517. Rest of South America Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 518. Asia Pacific Topical Pain Relief Sales, by Country K Units (2023-2028)
  • Table 519. Asia Pacific Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 520. Asia Pacific Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 521. Asia Pacific Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 522. Asia Pacific Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 523. Asia Pacific Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 524. China Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 525. China Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 526. China Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 527. China Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 528. China Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 529. Japan Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 530. Japan Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 531. Japan Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 532. Japan Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 533. Japan Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 534. India Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 535. India Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 536. India Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 537. India Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 538. India Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 539. South Korea Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 540. South Korea Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 541. South Korea Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 542. South Korea Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 543. South Korea Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 544. Taiwan Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 545. Taiwan Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 546. Taiwan Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 547. Taiwan Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 548. Taiwan Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 549. Australia Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 550. Australia Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 551. Australia Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 552. Australia Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 553. Australia Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 554. Rest of Asia-Pacific Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 555. Rest of Asia-Pacific Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 556. Rest of Asia-Pacific Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 557. Rest of Asia-Pacific Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 558. Rest of Asia-Pacific Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 559. Europe Topical Pain Relief Sales, by Country K Units (2023-2028)
  • Table 560. Europe Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 561. Europe Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 562. Europe Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 563. Europe Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 564. Europe Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 565. Germany Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 566. Germany Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 567. Germany Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 568. Germany Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 569. Germany Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 570. France Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 571. France Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 572. France Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 573. France Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 574. France Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 575. Italy Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 576. Italy Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 577. Italy Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 578. Italy Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 579. Italy Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 580. United Kingdom Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 581. United Kingdom Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 582. United Kingdom Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 583. United Kingdom Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 584. United Kingdom Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 585. Netherlands Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 586. Netherlands Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 587. Netherlands Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 588. Netherlands Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 589. Netherlands Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 590. Rest of Europe Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 591. Rest of Europe Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 592. Rest of Europe Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 593. Rest of Europe Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 594. Rest of Europe Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 595. MEA Topical Pain Relief Sales, by Country K Units (2023-2028)
  • Table 596. MEA Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 597. MEA Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 598. MEA Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 599. MEA Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 600. MEA Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 601. Middle East Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 602. Middle East Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 603. Middle East Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 604. Middle East Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 605. Middle East Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 606. Africa Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 607. Africa Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 608. Africa Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 609. Africa Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 610. Africa Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 611. North America Topical Pain Relief Sales, by Country K Units (2023-2028)
  • Table 612. North America Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 613. North America Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 614. North America Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 615. North America Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 616. North America Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 617. United States Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 618. United States Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 619. United States Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 620. United States Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 621. United States Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 622. Canada Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 623. Canada Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 624. Canada Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 625. Canada Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 626. Canada Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 627. Mexico Topical Pain Relief Sales, by Type K Units (2023-2028)
  • Table 628. Mexico Topical Pain Relief Sales, by Application K Units (2023-2028)
  • Table 629. Mexico Topical Pain Relief Sales, by Distribution Channel K Units (2023-2028)
  • Table 630. Mexico Topical Pain Relief Sales, by Formulation K Units (2023-2028)
  • Table 631. Mexico Topical Pain Relief Sales, by Therapeutic Class K Units (2023-2028)
  • Table 632. Topical Pain Relief: by Type(USD/Units)
  • Table 633. Research Programs/Design for This Report
  • Table 634. Key Data Information from Secondary Sources
  • Table 635. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Topical Pain Relief: by Type USD Million (2017-2022)
  • Figure 5. Global Topical Pain Relief: by Application USD Million (2017-2022)
  • Figure 6. Global Topical Pain Relief: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Topical Pain Relief: by Formulation USD Million (2017-2022)
  • Figure 8. Global Topical Pain Relief: by Therapeutic Class USD Million (2017-2022)
  • Figure 9. South America Topical Pain Relief Share (%), by Country
  • Figure 10. Asia Pacific Topical Pain Relief Share (%), by Country
  • Figure 11. Europe Topical Pain Relief Share (%), by Country
  • Figure 12. MEA Topical Pain Relief Share (%), by Country
  • Figure 13. North America Topical Pain Relief Share (%), by Country
  • Figure 14. Global Topical Pain Relief: by Type K Units (2017-2022)
  • Figure 15. Global Topical Pain Relief: by Application K Units (2017-2022)
  • Figure 16. Global Topical Pain Relief: by Distribution Channel K Units (2017-2022)
  • Figure 17. Global Topical Pain Relief: by Formulation K Units (2017-2022)
  • Figure 18. Global Topical Pain Relief: by Therapeutic Class K Units (2017-2022)
  • Figure 19. South America Topical Pain Relief Share (%), by Country
  • Figure 20. Asia Pacific Topical Pain Relief Share (%), by Country
  • Figure 21. Europe Topical Pain Relief Share (%), by Country
  • Figure 22. MEA Topical Pain Relief Share (%), by Country
  • Figure 23. North America Topical Pain Relief Share (%), by Country
  • Figure 24. Global Topical Pain Relief: by Type USD/Units (2017-2022)
  • Figure 25. Global Topical Pain Relief share by Players 2022 (%)
  • Figure 26. Global Topical Pain Relief share by Players (Top 3) 2022(%)
  • Figure 27. Global Topical Pain Relief share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 31. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 32. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 33. GlaxoSmithKline plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 35. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Reckitt Benckiser Group Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Reckitt Benckiser Group Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 39. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 40. Sanofi S.A. (France) Revenue: by Geography 2022
  • Figure 41. Topical BioMedics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Topical BioMedics, Inc. (United States) Revenue: by Geography 2022
  • Figure 43. AdvaCare Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 44. AdvaCare Pharma (United States) Revenue: by Geography 2022
  • Figure 45. Sun Pharmaceutical Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 46. Sun Pharmaceutical Industries Limited (India) Revenue: by Geography 2022
  • Figure 47. Troy Healthcare, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 48. Troy Healthcare, LLC (United States) Revenue: by Geography 2022
  • Figure 49. Global Topical Pain Relief: by Type USD Million (2023-2028)
  • Figure 50. Global Topical Pain Relief: by Application USD Million (2023-2028)
  • Figure 51. Global Topical Pain Relief: by Distribution Channel USD Million (2023-2028)
  • Figure 52. Global Topical Pain Relief: by Formulation USD Million (2023-2028)
  • Figure 53. Global Topical Pain Relief: by Therapeutic Class USD Million (2023-2028)
  • Figure 54. South America Topical Pain Relief Share (%), by Country
  • Figure 55. Asia Pacific Topical Pain Relief Share (%), by Country
  • Figure 56. Europe Topical Pain Relief Share (%), by Country
  • Figure 57. MEA Topical Pain Relief Share (%), by Country
  • Figure 58. North America Topical Pain Relief Share (%), by Country
  • Figure 59. Global Topical Pain Relief: by Type K Units (2023-2028)
  • Figure 60. Global Topical Pain Relief: by Application K Units (2023-2028)
  • Figure 61. Global Topical Pain Relief: by Distribution Channel K Units (2023-2028)
  • Figure 62. Global Topical Pain Relief: by Formulation K Units (2023-2028)
  • Figure 63. Global Topical Pain Relief: by Therapeutic Class K Units (2023-2028)
  • Figure 64. South America Topical Pain Relief Share (%), by Country
  • Figure 65. Asia Pacific Topical Pain Relief Share (%), by Country
  • Figure 66. Europe Topical Pain Relief Share (%), by Country
  • Figure 67. MEA Topical Pain Relief Share (%), by Country
  • Figure 68. North America Topical Pain Relief Share (%), by Country
  • Figure 69. Global Topical Pain Relief: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Novartis International AG (Switzerland)
  • Johnson & Johnson (United States)
  • GlaxoSmithKline plc. (United Kingdom)
  • Pfizer Inc. (United States)
  • Reckitt Benckiser Group Plc. (United Kingdom)
  • Sanofi S.A. (France)
  • Topical BioMedics, Inc. (United States)
  • AdvaCare Pharma (United States)
  • Sun Pharmaceutical Industries Limited (India)
  • Troy Healthcare, LLC (United States)
Additional players considered in the study are as follows:
Emami Group (India) , Exzell Pharma Inc. (Canada) , Performance Health Technologies, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 204 Pages 63 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Topical Pain Relief Market Quantitative research analysis
Global Topical Pain Relief Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Novartis International AG (Switzerland), Johnson & Johnson (United States), GlaxoSmithKline plc. (United Kingdom), Pfizer Inc. (United States), Reckitt Benckiser Group Plc. (United Kingdom), Sanofi S.A. (France), Topical BioMedics, Inc. (United States), AdvaCare Pharma (United States), Sun Pharmaceutical Industries Limited (India) and Troy Healthcare, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing demand for topical pain relief products by sportsperson" is seen as one of major influencing trends for Topical Pain Relief Market during projected period 2022-2028.
The Topical Pain Relief market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Topical Pain Relief Market Report?

Have a Query? Click Here

Other Related Reports

Atenolol Tablets Comprehensive Study by Application (Hypertension, Angina, Arrhythmias), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Prescription Mode (Prescript...
$ 3450
TB Vaccines Comprehensive Study by Type (Attenuated, Booster), Application (Hospitals, Clinical Labs, Pharmaceuticals), Distribution Channel (Online, Offline), Age Group (Pediatric, 16 Years – 35 Yea...
$ 3800
Atovaquone Comprehensive Study by Type (750mg, 5mL Oral suspension, 250mg/100mg, 62.5mg/25mg), Application (Ant malarial treatment, Pneumonia (Pneumocystis carinii), Others), Distribution Channel (On...
$ 3750
Terbinafine Hydrochloride Drug Comprehensive Study by Application (Athlete's Foot, Jock Itch, Ringworm, Others), Route of Administration (Topical, Oral), Duration of therapy (Fingernail onychomycosis...
$ 3450
Specialty Supplements Comprehensive Study by Application (Skin Care, Hair Care, Nutritional Deficiency, Cardiac Care, Mind Care, Others), Sales (Online, Offline), Form (Liquid, Powder, Capsule), Ingr...
$ 3450
Commercial Pharmaceutical Analytics Comprehensive Study by Type (Descriptive analytics, Predictive analytics, Prescriptive analytics), Application (Research & Development, Marketing & Sales, Supply C...
$ 3450